MedPath

Intervention to Promote Changes of Healthy Lifestyle (Physical Activity and Nutrition) During Gestation

Not Applicable
Completed
Conditions
Excessive Weight Gain During Pregnancy
Gestational Diabetes
Registration Number
NCT01782105
Lead Sponsor
Université de Sherbrooke
Brief Summary

The purpose of this study are:

* Assess the impact of an intervention to the adoption of healthy lifestyles among pregnant women at high risk of gestational diabetes mellitus on:

* weight gain in pregnancy

* the levels of maternal and fetal adipokines and

* glycemic control maternal and fetal.

* Determine whether the adoption of healthy lifestyles in pregnancy is associated with epigenetic changes that influence the levels of adipokines and glucose regulation during pregnancy and in newborns.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
16
Inclusion Criteria
  • be aged ≥ 18 years,
  • have a pre-pregnancy BMI ≥ 25 kg/m2,
  • be at risk of developing a gestational diabetes mellitus (a history of gestational diabetes mellitus or glucose 1 hour post-50g > 7.1 mmol/L.
Exclusion Criteria
  • Pre-pregnancy diabetes detected in the first trimester (A1c > 6.5%, fasting glucose > 7.0 mmol/L, random blood glucose> 11.1 mmol/L, glucose > 10.3 mmol/L 1 hour post-50g)
  • twin pregnancy
  • taking medications that can affect blood sugar or weight,
  • practice ≥ 150 minutes of physical activity per week
  • against formal-indication for physical activity.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Weight change during pregnancyWeeks 12, 24, 36 of gestation
Secondary Outcome Measures
NameTimeMethod
Levels of maternal and fetal adipokinesWeeks 12, 24 of gestation and at delivery (in cord blood)
Maternal and fetal glycemic controlWeeks 12, 24 of gestation and at delivery

Results of glucose tolerance test (50g and 75g)

Determine whether the adoption of healthy lifestyle in pregnancy is associated with epigenetic changes that influence the levels of adipokines and glucose regulation during pregnancy and in newborns.Weeks 12, 24 of gestation and at delivery (cord blood)
Optimize the intervention before measuring its impact on the prevention of gestational diabetes mellitus on a larger scale.throughout the study

Documentation will be collected about appreciation of the participants and attendance.

Trial Locations

Locations (1)

Centre Hospitalier Universitaire de Sherbrooke

🇨🇦

Sherbrooke, Quebec, Canada

Centre Hospitalier Universitaire de Sherbrooke
🇨🇦Sherbrooke, Quebec, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.